Delta Air Lines, Inc. vs Revvity Inc — how do they compare? Delta Air Lines, Inc. trades at $85.89 (market cap $56.23B), while Revvity Inc trades at $110.91 (market cap $12.41B). The key difference: Delta Air Lines, Inc. is far larger — about 4.5× Revvity Inc's market cap, and Delta Air Lines, Inc. pays the higher dividend (0.91%). Which is the better fit depends on your goals.
| DAL | RVTY | |
|---|---|---|
Market Cap | $56.23B | $12.41B |
Sector | Industrials | Technology |
52-Week High | $93.66 | $117.75 |
52-Week Low | $51.15 | $82.26 |
Enterprise Value | $71.55B | $14.90B |
Dividend Yield | 0.91% | 0.25% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
RVTY trades at $111.11, down 1.05% today, with a bullish technical signal from moving averages. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $1.06 exceeding expectations. Recent developments include AI integration with Anthropic's Claude and FDA clearance for a testosterone assay, signaling innovation in diagnostics and life sciences.
The outlook remains positive with strong analyst support (51.72% buy ratings) and a consensus price target of $111.43. Key risks include margin pressure from China divestment plans and weak academic demand. Revenue stability around $2.9B supports valuation, though high P/E of 53.47 requires sustained growth to justify.
Trailing returns across standard periods
Latest headlines on both assets
Atlanta-based Delta Air Lines is one of the world's largest airlines, with a network of over 300 destinations in more than 50 countries. Delta operates a hub-and-spoke system network, where it gathers and distributes passengers across the globe through key locations such as Atlanta, New York, Salt Lake City, Detroit, Seattle, and Minneapolis-St. Paul. Delta's sale of frequent flier miles, particularly to American Express, is a major driver of the firm's profits.
Read more on DAL →Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →